PGAP3 and breast cancer: To evaluate the stability of hsa_circ_0007990, we treated BC cells with RNase R (a 3’ to 5’ exoribonuclease that degrades linear RNA) and found that, compared with linear PGAP3 mRNA, hsa_circ_0007990 was resistant to RNase R (Fig. 1C).